Mark Philip Cleared of All Charges After Indictments

February 2, 2012 - All charges against Mark Philip, the former president of Hopkinton, Mass.-based Stryker Biotech, have been dropped as of February 2, 2012. Represented by Stephen Huggard, partner and chair of the firm’s white collar and government enforcement practice group, Philip is now free and clear of charges following two indictments in 2009 and 2011.

 

“We applaud the government for recognizing that fairness and justice required the case to be dismissed," said Huggard. "It is not easy for the government to acknowledge that charges were perhaps brought in error, and in this case, U.S. Attorney Carmen Ortiz deserves special credit for diving into the facts of the matter and making the hard, difficult decision to dismiss the case.

 

The indictments alleged that Philip, along with the company and three former sales managers, committed fraud against surgeons and the FDA with respect to Stryker Biotech's promotion of two medical devices, serious charges in the medical industry. Together with his co-defendants, for whom charges were dismissed in January 2012, Philip demonstrated that neither the surgeons nor the FDA was defrauded, and that Philip acted in good faith at all times as president of Stryker Biotech.

 

“We said at the outset that Mark was a good and decent family man, innocent of these charges. We are pleased that he can now resume his life without the burden of this case,” added Huggard. “We are proud to have represented a man of Mark’s character and perseverance, demonstrated to us over the past three and a half years. We wish him much success and happiness as he moves forward.”